Literature DB >> 12434693

Monitoring antibiotic resistance in urinary isolates from the community--a spotter practice model.

J Richards1.   

Abstract

Awareness of the rise in antimicrobial resistance has led to recommendations for better prescribing guidelines, based on accurate laboratory sensitivity data. However, concerns have been raised of possible biases in sampling leading to skewed resistance rates results, and so a range of different enhanced surveillance models have been proposed. This study compared the differences between routine results from unselected primary care urine samples with results from samples from spotter practices. Five hundred and eighty-eight out of 2,288 urine samples received from three spotter practices were culture positive. Of the 510 isolates tested against a panel of commonly prescribed antibiotics, levels of resistance to ampicillin were 32.5%, and to trimethoprim 18.0% (p < 0.05). By comparison, of 40,026 urine specimens submitted by other practices, 9,382 were culture positive and the percentage antibiotic resistant was higher--36.3% to ampicillin and 22.6% to trimethoprim. Routinely submitted laboratory samples may overestimate the true levels of antibiotic resistance in the community. A spotter practice-model is an effective and viable way of collecting unbiased data.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12434693

Source DB:  PubMed          Journal:  Commun Dis Public Health        ISSN: 1462-1843


  5 in total

1.  Can routine laboratory data guide empirical prescribing?

Authors:  H Ludlam; O Sule; M Knapton; I Abubakar
Journal:  J Clin Pathol       Date:  2004-06       Impact factor: 3.411

2.  Problems of basing patient recruitment for primary care studies on routine laboratory submissions.

Authors:  Cliodna McNulty; Michael Thomas; Rhiannon John; Andrew Lovering; Deirdre Lewis; Alasdair MacGowan
Journal:  J Clin Pathol       Date:  2007-03-02       Impact factor: 3.411

3.  Impact of Changing Patterns of Antimicrobial Resistance in Uropathogens: Emerging Treatment and Strategies.

Authors:  Patricia D. Brown
Journal:  Curr Infect Dis Rep       Date:  2003-12       Impact factor: 3.725

4.  Integrating Escherichia coli antimicrobial susceptibility data from multiple surveillance programs.

Authors:  John M Stelling; Karin Travers; Ronald N Jones; Philip J Turner; Thomas F O'Brien; Stuart B Levy
Journal:  Emerg Infect Dis       Date:  2005-06       Impact factor: 6.883

5.  Antimicrobial management and appropriateness of treatment of urinary tract infection in general practice in Ireland.

Authors:  Akke Vellinga; Martin Cormican; Belinda Hanahoe; Kathleen Bennett; Andrew W Murphy
Journal:  BMC Fam Pract       Date:  2011-10-03       Impact factor: 2.497

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.